[HTML][HTML] Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease

P Navarro, L Gutiérrez-Ramírez, A Tejera-Muñoz… - Nutrients, 2023 - mdpi.com
Background: Non-alcoholic fatty liver disease (NAFLD) is a common concomitant condition
in patients with inflammatory bowel disease (IBD). We aim to assess the magnitude of this …

Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease

P Navarro, L Gutiérrez-Ramírez, A Tejera-Muñoz… - Nutrients, 2023 - search.proquest.com
Background: Non-alcoholic fatty liver disease (NAFLD) is a common concomitant condition
in patients with inflammatory bowel disease (IBD). We aim to assess the magnitude of this …

Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease

P Navarro, L Gutiérrez-Ramírez… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Non-alcoholic fatty liver disease (NAFLD) is a common concomitant condition in
patients with inflammatory bowel disease (IBD). We aim to assess the magnitude of this …

Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease.

P Navarro, L Gutiérrez-Ramírez, A Tejera-Muñoz… - Nutrients, 2023 - europepmc.org
Background Non-alcoholic fatty liver disease (NAFLD) is a common concomitant condition in
patients with inflammatory bowel disease (IBD). We aim to assess the magnitude of this …

Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease

P Navarro, L Gutiérrez-Ramírez, A Tejera-Muñoz… - Nutrients, 2023 - agris.fao.org
Background: Non-alcoholic fatty liver disease (NAFLD) is a common concomitant condition
in patients with inflammatory bowel disease (IBD). We aim to assess the magnitude of this …

Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease.

P Navarro, L Gutiérrez-Ramírez, A Tejera-Muñoz… - Nutrients, 2023 - go.gale.com
Background: Non-alcoholic fatty liver disease (NAFLD) is a common concomitant condition
in patients with inflammatory bowel disease (IBD). We aim to assess the magnitude of this …

Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease.

P Navarro, L Gutiérrez-Ramírez, A Tejera-Muñoz… - …, 2023 - search.ebscohost.com
Background: Non-alcoholic fatty liver disease (NAFLD) is a common concomitant condition
in patients with inflammatory bowel disease (IBD). We aim to assess the magnitude of this …

[PDF][PDF] Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease …

P Navarro, L Gutiérrez-Ramírez, A Tejera-Muñoz… - 2023 - serviciodigestivotomelloso.es
Background: Non-alcoholic fatty liver disease (NAFLD) is a common concomitant condition
in patients with inflammatory bowel disease (IBD). We aim to assess the magnitude of this …

[HTML][HTML] Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease

P Navarro, L Gutiérrez-Ramírez, A Tejera-Muñoz… - Nutrients, 2023 - ncbi.nlm.nih.gov
Background: Non-alcoholic fatty liver disease (NAFLD) is a common concomitant condition
in patients with inflammatory bowel disease (IBD). We aim to assess the magnitude of this …

Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease.

P Navarro, L Gutiérrez-Ramírez, A Tejera-Muñoz… - Nutrients, 2023 - europepmc.org
Background Non-alcoholic fatty liver disease (NAFLD) is a common concomitant condition in
patients with inflammatory bowel disease (IBD). We aim to assess the magnitude of this …